PROBLEM TO BE SOLVED: To provide fusion molecules to be used in treatment of a patient suffering from light to moderate SLE.SOLUTION: In various embodiments, the present invention provides methods, compositions, dosing, and administration schedules for treating autoimmune diseases including systemic lupus erythematosus (SLE), which comprise administration of a TACI-Ig fusion molecule such as atacicept to a patient in need of such treatment. In one embodiment, the TACI-Ig fusion molecule is administered in an amount sufficient enough to slow, suppress or inhibit the proliferation-inducing function of BLyS and APRIL, in particular, the use of multiple administrations of the fusion molecule at relatively low dose over the course of the treatment.SELECTED DRAWING: None
DOSING METHOD FOR TREATING AUTOIMMUNE DISEASES BY USING TACI-Ig FUSION PROTEIN SUCH AS ATACICEPT